Time trends in prostate cancer screening in Swiss primary care (2010 to 2017) – A retrospective study-Reference-Cited by-同舟云学术

Time trends in prostate cancer screening in Swiss primary care (2010 to 2017) – A retrospective study

Published:2019-06-13 Issue:6 Volume:14 Page:e0217879
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zechmann Stefan^ORCID,Di Gangi Stefania,Kaplan Vladimir,Meier Rahel,Rosemann Thomas^ORCID,Valeri Fabio,Senn Oliver,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. Mortality results from a randomized prostate-cancer screening trial;GL Andriole;N Engl J Med,2009

2. Screening and prostate-cancer mortality in a randomized European study;FH Schroder;N Engl J Med,2009

3. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population;PC Robinson;The Journal of Rheumatology,2015

4. SwissMedicalBoard. Stellenwert des PSA-Wertes bei der Früherkennung des Prostatakarzinoms. 2011;http://www.medical-board.ch/fileadmin/docs/public/mb/medienmitteilungen/2011_11_11_Medienmitteilung_SwissMedicalBoardPSA_Bericht.pdf.

5. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement;VA Moyer;Ann Intern Med,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world treatment patterns and medical costs of prostate cancer patients in Switzerland – A claims data analysis;European Journal of Cancer;2024-06

2. Uso del antígeno prostático específico (PSA) para el cribado de cáncer de próstata en la población de 70 años o más de una zona de salud urbana, 2018-2020. Un estudio transversal;Medicina de Familia. SEMERGEN;2023-01

3. Smarter Medicine in der ambulanten Allgemeinen Inneren Medizin;Therapeutische Umschau;2021-09

4. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines;PLOS ONE;2020-04-16